Literature DB >> 34035320

Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture.

Andrea Antonio Ellero1,2, Iman van den Bout2,3, Maré Vlok4, Allan Duncan Cromarty1, Tracey Hurrell5.   

Abstract

Three-dimensional models are considered a powerful tool for improving the concordance between in vitro and in vivo phenotypes. However, the duration of spheroid culture may influence the degree of correlation between these counterparts. When using immortalised cell lines as model systems, the assumption for consistency and reproducibility is often made without adequate characterization or validation. It is therefore essential to define the biology of each spheroid model by investigating proteomic dynamics, which may be altered relative to culture duration. As an example, we assessed the influence of culture duration on the relative proteome abundance of HepG2 cells cultured as spheroids, which are routinely used to model aspects of the liver. Quantitative proteomic profiling of whole cell lysates labelled with tandem-mass tags was conducted using liquid chromatography-tandem mass spectrometry (LC-MS/MS). In excess of 4800 proteins were confidently identified, which were shared across three consecutive time points over 28 days. The HepG2 spheroid proteome was divergent from the monolayer proteome after 14 days in culture and continued to change over the successive culture time points. Proteins representing the recognised core hepatic proteome, cell junction, extracellular matrix, and cell adhesion proteins were found to be continually modulated.

Entities:  

Year:  2021        PMID: 34035320     DOI: 10.1038/s41598-021-89907-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  New drugs: where did we go wrong and what can we do better?

Authors:  Beate Wieseler; Natalie McGauran; Thomas Kaiser
Journal:  BMJ       Date:  2019-07-10

2.  Phase II and phase III failures: 2013-2015.

Authors:  Richard K Harrison
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

3.  Raising the bar for market authorisation of new drugs.

Authors:  Huseyin Naci; Jonathan Cylus; Sotiris Vandoros; Azusa Sato; Kumar Perampaladas
Journal:  BMJ       Date:  2012-08-07

4.  Biotech R&D spend jumps by more than 15.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2016-06-30       Impact factor: 84.694

Review 5.  Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.

Authors:  María José Gómez-Lechón; Laia Tolosa
Journal:  Arch Toxicol       Date:  2016-06-20       Impact factor: 5.153

Review 6.  Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.

Authors:  Volker M Lauschke; Delilah F G Hendriks; Catherine C Bell; Tommy B Andersson; Magnus Ingelman-Sundberg
Journal:  Chem Res Toxicol       Date:  2016-09-23       Impact factor: 3.739

7.  Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.

Authors:  Melissa Baxter; Sarah Withey; Sean Harrison; Charis-Patricia Segeritz; Fang Zhang; Rebecca Atkinson-Dell; Cliff Rowe; Dave T Gerrard; Rowena Sison-Young; Roz Jenkins; Joanne Henry; Andrew A Berry; Lisa Mohamet; Marie Best; Stephen W Fenwick; Hassan Malik; Neil R Kitteringham; Chris E Goldring; Karen Piper Hanley; Ludovic Vallier; Neil A Hanley
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

8.  Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.

Authors:  Catherine C Bell; Anita C A Dankers; Volker M Lauschke; Rowena Sison-Young; Roz Jenkins; Cliff Rowe; Chris E Goldring; Kevin Park; Sophie L Regan; Tracy Walker; Chris Schofield; Audrey Baze; Alison J Foster; Dominic P Williams; Amy W M van de Ven; Frank Jacobs; Jos van Houdt; Tuula Lähteenmäki; Jan Snoeys; Satu Juhila; Lysiane Richert; Magnus Ingelman-Sundberg
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 9.  Potential of human induced pluripotent stem cells in studies of liver disease.

Authors:  Fotios Sampaziotis; Charis-Patricia Segeritz; Ludovic Vallier
Journal:  Hepatology       Date:  2015-02-10       Impact factor: 17.425

10.  Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile.

Authors:  James A Heslop; Cliff Rowe; Joanne Walsh; Rowena Sison-Young; Roz Jenkins; Laleh Kamalian; Richard Kia; David Hay; Robert P Jones; Hassan Z Malik; Stephen Fenwick; Amy E Chadwick; John Mills; Neil R Kitteringham; Chris E P Goldring; B Kevin Park
Journal:  Arch Toxicol       Date:  2016-04-02       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.